A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine.
20 hours ago
5 / 5 (4) | 0
Effective treatment for DCIS is vital for continued reduction in Australia's breast cancer mortality rate
Variations in the treatment of DCIS (Ductal Carcinoma In Situ or precancerous cells of the breast) may be a contributing factor in worldwide differences in breast cancer mortality rates according to Professor ...
Aug 18, 2014
not rated yet | 0